mifepristone has been researched along with Cancer of Kidney in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, JH; Kim, S; Kwon, TK; Min, KJ; Park, JW | 1 |
| Check, D; Check, JH; Lofberg, P; Wilson, C | 1 |
| Check, D; Check, JH; Cohen, R; Dix, E; Wilson, C | 1 |
| Fujii, Y; Iwai, A; Kageyama, Y; Kawakami, S; Kihara, K; Takazawa, R; Yoshida, MA | 1 |
4 other study(ies) available for mifepristone and Cancer of Kidney
| Article | Year |
|---|---|
RU486 Induces Pro-Apoptotic Endoplasmic Reticulum Stress Through the Induction of CHOP Expression by Enhancing C/EBPδ Expression in Human Renal Carcinoma Caki Cells.
Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Binding Sites; Carcinoma, Renal Cell; CCAAT-Enhancer-Binding Protein-delta; Cell Line, Tumor; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Mifepristone; Promoter Regions, Genetic; Regulatory Factor X Transcription Factors; RNA Splicing; Transcription Factor CHOP; Transcription Factors; Transcriptional Activation; X-Box Binding Protein 1 | 2016 |
Long-term High-quality Survival with Single-agent Mifepristone Treatment Despite Advanced Cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Hormone Antagonists; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Mifepristone; Neoplasms; Survival Rate | 2016 |
Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Colonic Neoplasms; Female; Histiocytoma, Malignant Fibrous; Hormone Antagonists; Humans; Kidney Neoplasms; Leiomyosarcoma; Male; Middle Aged; Mifepristone; Neoplasms; Palliative Care; Pancreatic Neoplasms; Receptors, Progesterone; Survival Rate; Thymus Neoplasms; Treatment Outcome; Young Adult | 2010 |
Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids.
Topics: Carcinoma, Renal Cell; Cell Proliferation; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Glucocorticoids; Humans; Immunoenzyme Techniques; Kidney Neoplasms; Mifepristone; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2004 |